Spots Global Cancer Trial Database for unsuitable or refused to radical cystectomy
Every month we try and update this database with for unsuitable or refused to radical cystectomy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression | NCT05957757 | Non-Muscle Inva... HER2 | RC48 Tislelizumab | 18 Years - | RenJi Hospital | |
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression | NCT05957757 | Non-Muscle Inva... HER2 | RC48 Tislelizumab | 18 Years - | RenJi Hospital |